The effect of HLA matching on early post-transplant infections in patients receiving triple ptcy-based GVHD prophylaxis

被引:0
|
作者
Marra, J. [1 ]
Galli, E. [1 ]
Giammarco, S. [1 ]
Chiusolo, P. [1 ,2 ]
Metafuni, E. [1 ]
Sora, F. [1 ,2 ]
Laurenti, L. [1 ,2 ]
Innocenti, I. [1 ]
Autore, F. [1 ]
Limongiello, M. A. [1 ]
Bacigalupo, A. [1 ,2 ]
Sica, S. [1 ,2 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P298
引用
收藏
页码:263 / 263
页数:1
相关论文
共 50 条
  • [21] Infectious and Non-Infectious Pulmonary Complications in HCT Patients Treated with Post Transplant Cyclophosphamide (PTCy) Based Gvhd Prophylaxis
    Taylor, Skyler
    Kim, Annie
    Cho, Paul
    Smith, Kinaya
    Hamadani, Mehdi
    Abedin, Sameem
    [J]. BLOOD, 2023, 142
  • [22] Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
    Bailen, Rebeca
    Kwon, Mi
    Pascual-Cascon, Maria Jesus
    Ferra, Christelle
    Sanz, Jaime
    Gallardo-Morillo, Anabel
    Garcia-Sola, Abel
    Torrent, Anna
    Jimenez-Lorenzo, Maria Jose
    Pinana, Jose Luis
    Montoro, Juan
    Oarbeascoa, Gillen
    Dorado, Nieves
    Gomez-Centurion, Ignacio
    Munoz, Cristina
    Martinez-Laperche, Carolina
    Anguita, Javier
    Buno, Ismael
    Diez-Martin, Jose Luis
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (02) : 541 - 553
  • [23] Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
    Rebeca Bailén
    Mi Kwon
    María Jesús Pascual-Cascón
    Christelle Ferrà
    Jaime Sanz
    Anabel Gallardo-Morillo
    Abel García-Sola
    Anna Torrent
    María José Jiménez-Lorenzo
    José Luis Piñana
    Juan Montoro
    Gillen Oarbeascoa
    Nieves Dorado
    Ignacio Gómez-Centurión
    Cristina Muñoz
    Carolina Martínez-Laperche
    Javier Anguita
    Ismael Buño
    José Luis Díez-Martín
    [J]. Annals of Hematology, 2021, 100 : 541 - 553
  • [24] The patient's cmv serological status is an independent factor for cmv infection (CMVi) in the post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis era
    Herruzo, B.
    Esquirol, A.
    Martin, C.
    Gago, B.
    Gallardo, A. I.
    Cuesta, M.
    Garcia, A.
    Sanchez, I.
    Martin, S.
    Doblas, A.
    Munoz, D.
    Perez, M.
    Mena, A.
    Pascual, M. J.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 279 - 280
  • [25] NK Cell Impairment after Haploidentical Allogeneic Hematopoietic Cell Transplant in Patients Receiving Post-Transplant Cyclophosphamide (PTCy)
    Rambaldi, Benedetta
    Kim, Haesook T.
    Reynolds, Carol
    Rai, Sharmila Chamling
    Gooptu, Mahasweta
    Koreth, John
    Cutler, Corey
    Nikiforow, Sarah
    Ho, Vincent T.
    Alyea, Edwin P.
    Antin, Joseph H.
    Wu, Catherine J.
    Soiffer, Robert J.
    Ritz, Jerome
    Romee, Rizwan
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S70 - S71
  • [26] Post-Transplant Cyclophosphamide Versus MTX-CSA As Gvhd Prophylaxis in HLA-Identical Sibling HSCT
    Bailen, Rebeca
    Pascual, Maria-Jesus
    Balsalobre, Pascual
    Gallardo-Morillo, Anabel
    Garcia-Sola, Abel
    Serrano, David
    Anguita, Javier
    Buno, Ismael
    Dorado Herrero, Nieves
    Solan, Laura
    Diez-Martin, Jose
    Kwon, Mi
    [J]. BLOOD, 2018, 132
  • [27] OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY): OUTCOMES IN HAPLOIDENTICAL VERSUS MATCHED OR MISMATCHED UNRELATED DONOR (MUD/MMURD) ALLOGRAFTS
    Little, Jessica S.
    Shapiro, Roman M.
    Aleissa, Muneerah M.
    Zhou, Guohai
    Koreth, John
    Antin, Joseph H.
    Cutler, Corey
    Nikiforow, Sarah
    Romee, Rizwan
    Issa, Nicolas C.
    Ho, Vincent T.
    Gooptu, Mahasweta
    Baden, Lindsey R.
    Soiffer, Robert J.
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 89 - 90
  • [28] Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Transplantation Compared to ATG-Based Prophylaxis
    Bailen, Rebeca
    Kwon, Mi
    Jesus Pascual-Cascon, Maria
    Torrent, Anna
    Ferra, Christelle M.
    Sanz, Jaime
    Doblas-Marquez, Alberto
    Benitez, Olga
    Pinana Sanchez, Jose Luis
    Oarbeascoa, Gillen
    Dorado, Nieves
    Cristina, Munoz
    Martinez-Laperche, Carolina
    Anguita, Javier
    Buno, Ismael
    Luis Diez-Martin, Jose
    [J]. BLOOD, 2019, 134
  • [29] POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY), ABATACEPT AND VEDOLIZUMAB IN GVHD PROPHYLAXIS IN HEMATOPOIETIC STEM CELLS TRANSPLANTATION FROM MATCHED UNRELATED AND HAPLOIDENTICAL DONORS IN PEDIATRIC ACUTE LEUKEMIA PATIENTS
    Shelikhova, Larisa
    Perminova, M.
    Molostova, O.
    Abrosimov, A.
    Ilushina, I.
    Dunaykina, M.
    Balashov, D.
    Muzalevsky, I.
    Radygina, S.
    Livshits, A.
    Popov, A.
    Litvinov, D.
    Novichkova, G.
    Maschan, A.
    Maschan, M.
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 300 - 301
  • [30] Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) with Tacrolimus and Methotrexate (Tac/MTX) Gvhd Prophylaxis in Patients with AML Undergoing Transplantation from Matched Related or Unrelated Donors
    Popat, Uday R.
    Saliba, Rima M.
    Olson, Amanda
    Mehta, Rohtesh S.
    Ahmed, Sairah
    Alousi, Amin M.
    Anderlini, Paolo
    Al-Atrash, Gheath
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hosing, Chitra M.
    Im, Jin Seon
    Kebriaei, Partow
    Khouri, Issa F.
    Marin, David
    Molldrem, Jeffrey J.
    Nieto, Yago
    Oran, Betul
    Qazilbash, Muzaffar H.
    Rezvani, Katy
    Rondon, Gabriela
    Shpall, E. J. J.
    Varma, Ankur
    Andersson, Borje S.
    Champlin, Richard E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)